A Chicago jury this week ordered Illinois drug maker AbbVie to pay more than $3 million in damages to a man who suffered a heart attack after years of using its testosterone replacement therapy drug AndroGel.
Critics of the ever-rising cost of healthcare in the United States need look no further than the rising expenses for new prescription drugs.
The U.S. Food and Drug Administration has identified a troubling number of reports of both pancreatitis and liver damage among patients taking the popular rheumatoid arthritis drug Actemra.
Families suing drug maker GlaxoSmithKline over alleged birth defects from their anti-nausea medication Zofran have raised new charges that the company hid safety data from the FDA and is blocking evidence of false advertising.
On February 1st, a Kentucky man filed the latest DePuy Attune knee lawsuit against Warsaw, Indiana-based DePuy Orthopedics, alleging that defective design of their Attune knee implants led to tibial loosening (link to Attune loosening page) and device failure.
An estimated 75% of the 10,000 children diagnosed with cerebral palsy each year will have a form called spastic cerebral palsy, which is characterized by chronic muscle tightness that makes movement and coordination difficult.
A federal appeals court recently signed an order resurrecting around 750 lawsuits filed against the makers of drugs like Januvia, Victoza, Janumet, Byetta/Bydureon, Trulicity and Tradjenta over links to pancreatic cancer.
Prescription drugs for type-2 diabetes have grown in popularity exponentially over the last few decades. With tens of millions of patients taking them each year, they’re now among the most widely used on the market.